Cargando…
Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
Iron (ferric carboxymaltose) infusion therapy is used to treat severe iron deficiency which is not responding to the first-line oral iron therapy. However, it can also cause severe renal wasting of phosphate resulting in severe hypophosphataemia in some patients. Despite the growing number of case r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689119/ https://www.ncbi.nlm.nih.gov/pubmed/31385673 http://dx.doi.org/10.1530/EDM-19-0065 |